CoreCap Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.28K Hold
500
– – ﹤0.01% 2297
2026
Q2
$2.85K Hold
500
– – ﹤0.01% 2446
2026
Q1
$1.94K Hold
500
– – ﹤0.01% 2421
2025
Q4
$2.09K Hold
500
– – ﹤0.01% 2467
2025
Q3
$1.64K Hold
500
– – ﹤0.01% 2407
2025
Q2
$710 Hold
500
– – ﹤0.01% 2469
2025
Q1
$745 Buy
+500
New +$787 ﹤0.01% 2593

Other funds holding PGEN

CoreCap Advisors's PGEN Position: Q3 2026 in Review

CoreCap Advisors held its Precigen (PGEN) position steady in Q3 2026 at 500 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

CoreCap Advisors first reported a position in PGEN in Q1 2025 and has held it in 7 quarters since. 29 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • CoreCap Advisors held 500 shares of Precigen worth $4.28K as of Q3 2026.
  • CoreCap Advisors left its Precigen share count unchanged in Q3 2026.
  • Precigen made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2297 holding.
  • CoreCap Advisors first reported a position in Precigen in Q1 2025 and has held it in 7 quarters since.
  • 29 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.